Skip to content

Clinical trials

Terminated Rectal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Status: Terminated Country / region: United States Clear all

128 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20025
20037
20047
20055
200611
20072
20087
20097
201013
20114
20137
20145
20154
20163
20171
20182
20196
20208
20213
20224
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated128

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)20
Stanford University5
Washington University School of Medicine5
Fox Chase Cancer Center4
M.D. Anderson Cancer Center4
Roswell Park Cancer Institute4
University of Southern California4
Alliance for Clinical Trials in Oncology3
NSABP Foundation Inc3
Vanderbilt-Ingram Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms128
Colonic Neoplasms88
Colorectal Neoplasms54
Carcinoma, Non-Small-Cell Lung10
Pancreatic Neoplasms10
Stomach Neoplasms10
Lung Neoplasms7
Neoplasm Metastasis7
Anus Neoplasms6
Breast Neoplasms6

Trials

Showing 1 to 25 of 128. Each trial links to its page on Pharma Observatory.

28 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.